A radiomics-based nomogram for differentiating minimally invasive adenocarcinoma from stage I invasive non-mucinous adenocarcinoma (CTR < 0.5, GGO-dominant).
The radiomics-based nomogram model demonstrates excellent predictive performance for differentiating MIA from stage I INMA in GGO-dominant lesions with CTR < 0.5, and provides valuable clinical support for personalized and precise diagnosis and treatment, thereby facilitating optimal patient management.